Leon Cooperman's DMAC Position Overview
Leon Cooperman (via Cooperman Leon G) currently holds 3.3M shares of DiaMedica Therapeutics Inc. (DMAC) worth $17.64 M, representing 0.55% of the portfolio. First purchased in 2020-Q4, this medium-term investment has been held for 20 quarters.
Based on 13F filings, Leon Cooperman has maintained a strategic position in DMAC, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2025, adding 1.6M shares.
Analysis based on 13F filings available since 2013 Q2
Leon Cooperman's DiaMedica Therapeutics (DMAC) Holding Value Over Time
Track share changes against reported price movement
Quarterly DiaMedica Therapeutics (DMAC) Trades by Leon Cooperman
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2020 | +30,000 | New Buy | 30,000 | $10.13 |
| Q1 2021 | +20,000 | Add 66.67% | 50,000 | $9.16 |
| Q3 2021 | +150,000 | Add 300.00% | 200,000 | $4.01 |
| Q4 2021 | +100,000 | Add 50.00% | 300,000 | $3.73 |
| Q1 2022 | +512,508 | Add 170.84% | 812,508 | $2.50 |
| Q1 2023 | +55,905 | Add 6.88% | 868,413 | $1.53 |
| Q2 2023 | +7,580 | Add 0.87% | 875,993 | $4.32 |
| Q4 2023 | +7,630 | Add 0.87% | 883,623 | $2.84 |
| Q2 2024 | +516,377 | Add 58.44% | 1.4 M | $2.95 |
| Q3 2024 | +111,739 | Add 7.98% | 1.51 M | $4.19 |
| Q4 2024 | +113,261 | Add 7.49% | 1.62 M | $5.43 |
| Q2 2025 | +25,000 | Add 1.54% | 1.65 M | $3.90 |
| Q3 2025 | +1.62 M | Add 98.17% | 3.27 M | $5.40 |
Leon Cooperman's DiaMedica Therapeutics Investment FAQs
Leon Cooperman first purchased DiaMedica Therapeutics Inc. (DMAC) in Q4 2020, acquiring 30,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Leon Cooperman has held DiaMedica Therapeutics Inc. (DMAC) for 20 quarters since Q4 2020. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Leon Cooperman's largest addition to DiaMedica Therapeutics Inc. (DMAC) was in Q3 2025, adding 3,269,761 shares worth $17.64 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Leon Cooperman's firm, Cooperman Leon G, owns 3,269,761 shares of DiaMedica Therapeutics Inc. (DMAC), valued at approximately $17.64 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, DiaMedica Therapeutics Inc. (DMAC) represents approximately 0.55% of Leon Cooperman's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Leon Cooperman's peak holding in DiaMedica Therapeutics Inc. (DMAC) was 3,269,761 shares, as reported at the end of Q3 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.